ADHD Medication With High Blood Pressure or a Heart Condition

Most adults with controlled high blood pressure can take ADHD medication with closer monitoring. Stimulants raise blood pressure by about 2 to 4 mm Hg on average, and that rise can be measured and treated. Serious structural heart disease is different, and stimulants are generally avoided there.1

I'm a psychiatrist. For patients with a known heart condition, these decisions are made together with their cardiologist or primary care doctor, who knows the cardiac picture better than I do.

What the stimulant labels say

The Adderall XR prescribing information states: "Avoid ADDERALL XR use in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmia, coronary artery disease, or other serious cardiac disease." It also notes that stimulants raise blood pressure by about 2 to 4 mm Hg and heart rate by about 3 to 6 beats per minute on average, and that all treated patients should be monitored for hypertension and tachycardia.1

Before starting, the label calls for a careful history, including any family history of sudden death or ventricular arrhythmia, and a physical exam.1 A positive answer on that history is a reason to see a cardiologist before the first dose.

Hypertension is handled differently. The label lists no blood pressure contraindication, and it directs clinicians to monitor every treated patient for hypertension and tachycardia.1

The long-term studies say little about existing heart disease

The largest long-term study, from Swedish registers, excluded people who had cardiovascular disease before baseline.3 Its finding of 23% higher odds of cardiovascular disease after five years of use applies to people who started with no cardiac diagnosis. Evidence for people who already have heart disease is thinner, which is one reason those decisions belong with a cardiologist.

Data on people with metabolic risk are beginning to appear. In a 2026 multinational cohort of adults with type 2 diabetes, ADHD medication use was associated with a higher rate of major adverse cardiac events among those diagnosed with diabetes before age 45 (hazard ratio 1.58, 95% CI 1.18 to 2.10).4 People with diabetes or prediabetes on ADHD medication warrant closer follow-up.

When blood pressure is high, treat the blood pressure

I have patients in this situation. The medication is appropriate, it's working, and the blood pressure is running high. Stopping the ADHD medication is one option among several, and it's rarely the first. The usual sequence is:

High blood pressure is among the strongest risk factors for heart attack and stroke, and it's also one of the most treatable. If monitoring keeps the number in a normal range, the medication is unlikely to be adding much risk.

ADHD medications that don't raise blood pressure

Guanfacine (Intuniv) is the exception among ADHD medications. In pooled randomized trials it lowered adult systolic blood pressure by about 10 mm Hg and pulse by about 7 beats per minute.2 That makes it useful for someone whose pressure runs high, alone or added to a lower stimulant dose. It's generally less effective for core ADHD symptoms than a stimulant, and it can cause sleepiness and lightheadedness.

The other nonstimulants still affect the heart. Atomoxetine (Strattera) and viloxazine (Qelbree) raise pulse and blood pressure in a range similar to stimulants.2, 6 See my comparison of nonstimulant ADHD medications.

Who needs closer attention

The risk factors that matter here are the same ones that matter for cardiovascular disease in general:

ADHD itself is associated with about twice the risk of cardiovascular disease in adults, independent of medication.5 That makes the ordinary prevention measures more valuable for this group. Regular aerobic exercise lowers blood pressure and also improves ADHD symptoms.

Common questions

Can you take Adderall with high blood pressure?

Often yes, if the blood pressure is controlled and monitored. Adderall raises blood pressure by about 2 to 4 mm Hg on average. Uncontrolled hypertension should be treated first, and the decision should involve the doctor managing your blood pressure.1

What ADHD medication doesn't raise blood pressure?

Guanfacine (Intuniv) lowers blood pressure and heart rate. Stimulants, atomoxetine (Strattera), and viloxazine (Qelbree) can raise them by small amounts.2

Can I take ADHD medication if I have AFib or SVT?

Stimulant labels advise avoiding use in people with serious cardiac arrhythmia. Whether a particular rhythm problem falls in that category is a question for your cardiologist, who should be part of the decision before any ADHD medication is started.1

Should I take blood pressure medication so I can stay on my ADHD medication?

It's a reasonable option when the ADHD medication is clearly helping and the dose is already as low as it can go. Blood pressure medications are effective, and controlling the pressure addresses the main cardiovascular concern with long-term ADHD treatment. Your primary care doctor should guide that choice.

Is ADHD medication safe for older adults?

Age raises baseline cardiovascular risk, so monitoring matters more. ADHD symptoms also tend to ease with age, and the dose that was right at 30 may be more than is needed at 60. Review the benefit, the dose, and the blood pressure with your doctor each year.

Chest pain, fainting, or shortness of breath during treatment needs immediate medical assessment. Seek emergency care for severe symptoms.1

Sources

  1. Adderall XR prescribing information, sections 2.1, 5.2, and 5.3. DailyMed.
  2. Farhat LC, et al. Comparative cardiovascular safety of medications for ADHD in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2025;12(5):355-365.
  3. Zhang L, et al. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases. JAMA Psychiatry. 2024;81(2):178-187.
  4. Dong Z, et al. Major adverse cardiac events and mortality associated with ADHD and its treatment in adults with type 2 diabetes: a multi-national cohort study. BMC Medicine. 2026;24(1):527.
  5. Li L, et al. Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study. World Psychiatry. 2022;21(3):452-459.
  6. Qelbree prescribing information. DailyMed.